CEO Total Pay
$20.8M
FY2023 Summary Compensation, well above median
DOW FY2023 SEC EDGAR DEF 14A
Dow Inc. CEO pay ratio
The CEO earned $20.8M in FY2023 against median worker pay of $94,600 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2024-03-01
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2023
Data updated August 2026
CEO-to-worker pay ratio
220:1
High (Scale: 0–1000:1)
CEO pay
$20.8M
Median worker
$94,600
Latest filing FY2023. This company's newest DEF 14A on file is for FY2023, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Dow Inc. reported a 220:1 CEO-to-worker pay ratio in FY2023 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 220:1
- FY2023 disclosed
- CEO total
- $20.8M
- Summary Compensation Table total
- Median worker
- $94,600
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2023
A component-level pay breakdown is not reported in Dow Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Dow Inc.
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2023. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
- Latest ratio
- 220:1
- FY2023
- vs prior FY
- 0:1
- from FY2022 220:1
- CEO $ YoY
- +6.9%
- $20.8M latest
- Filings shown
- 3
- FY2021–2023
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $24.9M | - | $95,607 | 260:1 | - |
| 2022 | $19.5M | -22% | $88,456 | 220:1 | -40:1 |
| 2023 | $20.8M | +6.9% | $94,600 | 220:1 | 0:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1751788, FY2021–2023. Adjacent-year deltas only.
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
220:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$20.8M
Companies in Industry
168
vs. Industry Median
Above
Dow Inc.: STEEP · PEAK pay ratio
Dow Inc. disclosed 220:1 CEO-to-worker pay and $20.8M CEO total in FY2023. the CEO earned 220× the median employee ($94,600) in FY2023.
Median employee $94,600 (HIGH-MED); STEEP · PEAK stamps put about 220 median-wage years per CEO year.
Pay Ratio
220:1
Elevated vs. peers
What FY2023 shows for Dow Inc.
Dow Inc. disclosed 220:1 CEO-to-worker pay and $20.8M CEO total in FY2023. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Dow Inc.'s $20.8M CEO total is above the $7.9M industry median CEO pay.
Dow Inc. stamps STEEP · PEAK · HIGH-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2023
- Total Compensation
- $20.8M
- Median Employee Pay
- $94,600
- Pay Ratio
- 220:1
- Filing Date
- 2024-03-01
Company Info
- Ticker
- DOW
- CIK
- 1751788
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2821
- State
- DE
SEC EDGAR DEF 14A for CIK 1751788, FY2023. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Dow Inc. disclosed 220:1 CEO-to-worker pay and $20.8M CEO total in FY2023.
Read with Dow Inc.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.
Stryker Corp · PEAK
ABS(ceo_total_comp) peer at $20.8M (Δ $44K lighter vs Dow Inc.); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
DraftKings Inc. · PEAK
ABS(ceo_total_comp) peer at $20.8M (Δ $54K lighter vs Dow Inc.); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
Nextpower Inc. · PEAK
ABS(ceo_total_comp) peer at $20.7M (Δ $102K lighter vs Dow Inc.); HIGH · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Amedisys Inc · PEAK
ABS(ceo_total_comp) peer at $20.7M (Δ $105K lighter vs Dow Inc.); HIGH · PAR-MED vs this page's STEEP · PEAK · HIGH-MED.
Chemicals & Pharmaceuticals benchmark
Dow Inc. stamps STEEP · PEAK · HIGH-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · STEEP
See where STEEP · PEAK packages sit on the national leaderboard after reading Dow Inc..
Comp structure · PEAK
Dow Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Dow Inc. (CIK 1751788), FY2023. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.